Laurie Heilmann

Laurie Heilmann has extensive experience in the biotechnology and healthcare industries. Laurie has held various strategic advisory and board roles at organizations such as BioLizard, Lavaa Health, Research Corporation Technologies, Agendia, AltheaDx, and Translational Drug Development. Laurie also served as the Chief Executive Officer of Notable, where they led cutting-edge cancer treatment efforts. Prior to that, they held executive positions at Crown Bioscience, Inc., where they played a key role in the company's growth and acquisition. Laurie also worked at Strong-Bridge LLC, where they established and led a successful healthcare and life science practice. Additionally, they served on the Advisory Board of SPRI Clinical Trials. With their diverse background and expertise, Laurie has consistently contributed to the strategic growth and success of the companies they have been involved with.

Laurie Heilmann received a Bachelor of Nursing degree in Registered Nursing/Registered Nurse from New Jersey City University at Ramapo College Englewood Medical Center from 1975 to 1981. Additionally, they obtained a Bachelor of Business Administration degree in Business Administration and Management, General from Kennedy Western University.